Pertuzumab (Perjeta) Injection: Uses, Dosage, Mechanism, Side Effects, and Important Advice

Pertuzumab (Perjeta) Injection: Uses, Dosage, Mechanism, Side Effects, and Important Advice

How Perjeta (Pertuzumab) is Used to Treat HER2-Positive Breast CancerПодробнее

How Perjeta (Pertuzumab) is Used to Treat HER2-Positive Breast Cancer

Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to KnowПодробнее

Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to Know

Anti-HER2 Mechanisms of Approved HER2 InhibitorsПодробнее

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

Understanding your treatment: Taxotere/Herceptin/Perjeta chemotherapyПодробнее

Understanding your treatment: Taxotere/Herceptin/Perjeta chemotherapy

Dr. Jahanzeb on the Benefit of Pertuzumab Plus Trastuzumab in HER2+ Breast CancerПодробнее

Dr. Jahanzeb on the Benefit of Pertuzumab Plus Trastuzumab in HER2+ Breast Cancer

Dr. José Baselga on Combining Pertuzumab (Perjeta) with Trastuzumab (Herceptin)Подробнее

Dr. José Baselga on Combining Pertuzumab (Perjeta) with Trastuzumab (Herceptin)

Trastuzumab Deruxtecan for Breast Cancer | NEJMПодробнее

Trastuzumab Deruxtecan for Breast Cancer | NEJM

#pertuzumab | Uses, Dosage, Side Effects & Mechanism | PerjetaПодробнее

#pertuzumab | Uses, Dosage, Side Effects & Mechanism | Perjeta

Drug cocktail called 'miracle' for breast cancerПодробнее

Drug cocktail called 'miracle' for breast cancer

Understanding your therapy: TCH with PerjetaПодробнее

Understanding your therapy: TCH with Perjeta

PRECIOUS: pertuzumab retreatment in patients with HER+ breast cancerПодробнее

PRECIOUS: pertuzumab retreatment in patients with HER+ breast cancer

The Optimal Duration of Pertuzumab Treatment for Patients With HER2+ Breast CancerПодробнее

The Optimal Duration of Pertuzumab Treatment for Patients With HER2+ Breast Cancer

ADAPT: de-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel in HR-/HER2+ eBCПодробнее

ADAPT: de-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel in HR-/HER2+ eBC

PHranceSCa: evaluating patient satisfaction with subcutaneous pertuzumab and trastuzumab treatmentПодробнее

PHranceSCa: evaluating patient satisfaction with subcutaneous pertuzumab and trastuzumab treatment

Which Chemotherapy With Adjuvant Trastuzumab and Pertuzumab?Подробнее

Which Chemotherapy With Adjuvant Trastuzumab and Pertuzumab?

Capivasertib Approved to Treat Patients with Advanced (HR+/HER2-) Breast Cancer │ PharmacologyПодробнее

Capivasertib Approved to Treat Patients with Advanced (HR+/HER2-) Breast Cancer │ Pharmacology

Dr. Pegram on Pertuzumab and Trastuzumab in Breast CancerПодробнее

Dr. Pegram on Pertuzumab and Trastuzumab in Breast Cancer

Understanding the Potential Side Effects of HerceptinПодробнее

Understanding the Potential Side Effects of Herceptin

CLEOPATRA: pertuzumab, trastuzumab & chemo for HER2+ mBCПодробнее

CLEOPATRA: pertuzumab, trastuzumab & chemo for HER2+ mBC